Search Results 251-260 of 16461 for Zonisamide

  1. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  3. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  4. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your doctor's ...

  5. Fidanacogene elaparvovec-dzkt (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Fidanacogene elaparvovec-dzkt injection is used to treat moderate to severe hemophilia B (congenital Factor IX deficiency) in patients who are ...

  6. Capivasertib (oral route) - Side effects & dosage - Mayo Clinic

    Capivasertib is used in combination with fulvestrant to treat HR-positive, HER-2 negative breast cancer that is advanced or metastatic (cancer that has spread) ...

  7. Cinacalcet (oral route) - Side effects & dosage - Mayo Clinic

    Cinacalcet is used to treat hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused ...

  8. Precision Medicine in Neurodegeneration: Nilufer Ertekin-Taner - Genetics of Alzheimer's Disease and Endophenotypes Laboratory

    The Precision Medicine in Neurodegeneration Lab led by Nilufer Ertekin-Taner, M.D., Ph.D., studies underlying genetic risk and protective factors involved ...

  9. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving selinexor, carfilzomib, and dexamethasone may be ...

  10. Oxaprozin (oral route) - Side effects & dosage - Mayo Clinic

    Appropriate studies have not been performed on the relationship of age to the effects Coxanto® and Daypro® to treat juvenile rheumatoid arthritis in children ...